Cancer Commons

08/16/2026

Honored to share this video from our wonderful partner Head For The Cure.

08/12/2026

Here’s the latest from our Curious Dr. George! Read “BCR-ABL: A Personal Journey into Precision Oncology—Our Chief Scientist’s role in the discovery that led to Gleevec and launched targeted therapy” here: bit.ly/CCCDGEmma

As Chief Scientist at Cancer Commons, Emma Shtivelman, PhD, applies her deep expertise and compassion to help cancer patients, their loved ones, and their care teams navigate personalized treatment options based on the best, most up-to-date evidence. But her influence extends far beyond the lives she’s touched directly. Our Curious Dr. George asks her about an early-career discovery that would help save many lives and usher in the era of precision oncology.

06/30/2026

Here’s the latest from our Curious Dr. George! Read “Using Real World Outcomes from ‘People Like Me’ to Guide Cancer Treatment” here: bit.ly/CCCDGPalmer

One of the most powerful questions a cancer patient can ask is, “What worked for other people like me?” The company PotentiaMetrics gets to the heart of that question with Capire360, its externally validated survival analytics engine trained on 2.2 million real-world cancer cases, and Ardynn, its Personalized Shared Decision Making (PDSM) platform, with support delivered through independent certified patient advocates.

Our Curious Dr. George asks Robert (Bobby) Palmer, MBA, founder and CEO of PotentiaMetrics, about how the 10-year-old company helps cancer patients, caregivers, and clinicians.

06/17/2026

Here’s the latest from our Curious Dr. George! Read "The Strong Helping Hand of Cancer Commons" here: bit.ly/CCCDGBakker

Cancer is frequently accompanied by psychological distress and mental health challenges that are often neglected. Our Curious Dr. George asks Unsha Bakker, MSN, RN, OCN, CBCN, Cancer Commons Oncology Nurse Navigator for the Brain Cancer Support and Solutions Alliance (BCSSA), for her perspective on these issues—and how Cancer Commons can help.

BCSSA is a collaboration between Head For The Cure, the Musella Foundation For Brain Tumor Research & Information, Inc., and Cancer Commons. Our Nurse Navigator program is made possible through generous grant support provided by Head for the Cure and the Musella Foundation.

05/12/2026

For 𝗕𝗿𝗮𝗶𝗻 𝗧𝘂𝗺𝗼𝗿 𝗔𝘄𝗮𝗿𝗲𝗻𝗲𝘀𝘀 𝗠𝗼𝗻𝘁𝗵, you're invited to a free webinar: 𝗛𝗮𝗿𝗻𝗲𝘀𝘀𝗶𝗻𝗴 𝗢𝘅𝘆𝗴𝗲𝗻 𝘁𝗼 𝗙𝗶𝗴𝗵𝘁 𝗕𝗿𝗮𝗶𝗻 𝗧𝘂𝗺𝗼𝗿𝘀 | TODAY Tuesday, May 12 at 4pm PT | 7pm ET

Tumor hypoxia (low oxygen in the tumor environment) is a key factor in glioblastoma's resistance to treatment. This webinar explores emerging approaches to reversing hypoxia and improving the efficacy of standard of care, featuring Dr. Nicholas Blondin of Yale Medicine.

Presented by our longtime partner, the Musella Foundation For Brain Tumor Research & Information, Inc. Link to attend: virtualtrials.org/webinar

05/06/2026

We are honored to celebrate and share this wonderful post from our partner Head For The Cure. Sending gratitude every day to 𝗨𝗻𝘀𝗵𝗮 𝗕𝗮𝗸𝗸𝗲𝗿, 𝗠𝗦𝗡, 𝗥𝗡, 𝗢𝗖𝗡, 𝗖𝗕𝗖𝗡, Brain Cancer Support and Solutions Alliance Nurse Navigator at Cancer Commons.

For National Nurses Day, we are proud to feature Unsha Bakker, MSN, RN, OCN, CBCN, our Brain Cancer Support and Solutions Alliance (BCSSA) Nurse Navigator.

In collaboration with Head for the Cure, the Musella Foundation For Brain Tumor Research & Information, Inc, and Cancer Commons, Unsha plays a pivotal role in supporting the brain tumor community. With over a decade of nursing experience, she brings both expertise and compassion to help patients navigate a brain tumor diagnosis.

“I have found my calling in oncology nursing. This field has deeply impacted me and has opened my heart tenfold. The patients and loved ones I interact with each day have brought new meaning to my life,” Unsha shares.

Learn more about Unsha and our work with the BCSSA:
https://www.cancercommons.org/bcssa

04/28/2026

Here’s the latest from our Curious Dr. George! Read Cancer Commons “Seeking Patients with Advanced Cancer for a New Clinical Study” here: bit.ly/CCCDGPillai

Cancer Commons has launched a new clinical study that features drug sensitivity testing—laboratory testing of individual patients’ cancer cells to identify drugs that might work for them. Our Curious Dr. George asks Cancer Commons Director of Clinical Sciences Prajit Pillai, PhD, MBA, about the study.